Revolade NZ CMI

Revolade is indicated in adult patients with chronic hepatitis C virus infection for the treatment of thrombocytopenia, where the degree of

Revolade Active substance Eltrombopag Holder Novartis Status Closed Indication patients aged 1 year and above with primary immune thrombocytopenia

revolade Wholesale Trader of Revolade Tablets

revolade Revolade Tablet 25 mg is a product of Novartis Ltd Its generic name is Eltrombopag Olamine